Strides Pharma Science Ltd → Gleanmark Pharmaceuticals Inc

Bill of Lading Import Record

Summary

The following Bill of Lading record outlines a container shipment imported into the US by GLEANMARK PHARMACEUTICALS INC. This shipment is registered as coming from STRIDES PHARMA SCIENCE LTD via Colombo Harbor,Sri Lanka with logistic notifications handled by GLENMARK PHARMACEUTICALS INC. Manifest records show a quanitity of 35 PCS with a total weight of 12745 Kilograms arrived on 2019-07-29 via the vessel CMA CGM TAGE to the port of New York/Newark Area, Newark, New Jersey. Cargo includes products identified as cargo is stowed in a refrigerated container s at the shipper's requested carrying temperatu of 20 degrees celsius freight prepaid nizatidine capsules usp 150 mg.60's inv no:9214002313 dt:28.06.2019 p.o.no:4300016680 dt:25.03.2019.

Cargo Details
Consignee
GLEANMARK PHARMACEUTICALS INC
301,ISLAND ROAD MAHWAH,NJ
IMPORTER DEA:RG0400553
DEA:RG0351495,-07430,USA

Shipper
STRIDES PHARMA SCIENCE LTD
(FORMERLY STRIDES SHASUN LTD)
FORMULATION DIVISION(100 EOU)
R.S.NO.32,33 34,PIMS ROAD,

Contact Details: PERIYAKALAPET,PUDUCHERRY, [Telephone Number]
Notify Party
GLENMARK PHARMACEUTICALS INC
301,ISLAND ROAD MAHWAH,NJ
IMPORTER DEA:RG0400553
DEA:RG0351495,07430,


Contact Details: USA,ISLAND FALLS-ME, [Telephone Number]
Vessel and Port
Carrier CodeAPLU
VesselCMA CGM TAGE [MT]
Departure PortColombo Harbor,Sri Lanka
Landing PortNew York/Newark Area, Newark, New Jersey
Manifest Qty35 PCS
Manifest Weight12745 Kilograms
Manifest Dimension0 Cubic Meters
Place of ReceiptCHENNAI
Conveyance ID9674555 [IMO Number/Lloyds Number]
Transportation ModeVessel, non-container
Arrival Date2019-07-29

Container Cargo Description
Container #PiecesDescription
TCLU107695035CARGO IS STOWED IN A REFRIGERATED CONTAINER S AT THE SHIPPER'S REQUESTED CARRYING TEMPERATU OF 20 DEGREES CELSIUS FREIGHT PREPAID NIZATIDINE CAPSULES USP 150 MG.60'S INV NO:9214002313 DT:28.06.2019 P.O.NO:4300016680 DT:25.03.2019
TCLU1076950NIZATIDINE CAPSULES USP 150MG,60'S NDC:68462042560/ ANDA 090618/ HTS:3004 40 00 40/ FDA PRODUCT CODE: 62 T A A 03/ DRUG ESTABLISHMENT
TCLU1076950CODE:3002808058 NIZATIDINE CAPSULES USP 300MG 30'S HTS:3004400040 FDA PRODUCT CODE:60SCA25 ANDA 78542DRUG ESTABLISHMENT CODE:3012448465
TCLU1076950RANITIDINE TABLETS USP 150 MG.500'S HTS:3004400040 FDA PRODUCT CODE:60SCA25 ANDA 78542 DRUG ESTABLISHMENT CODE:3012448465
TCLU1076950NDC :68462-248-05 RANITIDINE TABLETS USP 150 MG.500'S HTS:3004400040 FDA PRODUCT CODE:60SCA25 ANDA 78542 DRUG ESTABLISHMENT CODE:3012448465
TCLU1076950NDC :68462-248-05

BoL Details
Master BOLHouse BOLVoyage NumberBill TypeManifest #Update / Run Date
APLUAQS0109284C () 0TU7URegular Bill12019-07-22 / 2019-07-30


© 2024 import.report | Privacy Policy